SU453842A3 - - Google Patents

Info

Publication number
SU453842A3
SU453842A3 SU1761120A SU1761120A SU453842A3 SU 453842 A3 SU453842 A3 SU 453842A3 SU 1761120 A SU1761120 A SU 1761120A SU 1761120 A SU1761120 A SU 1761120A SU 453842 A3 SU453842 A3 SU 453842A3
Authority
SU
USSR - Soviet Union
Prior art keywords
compound
general formula
group
solution
compounds
Prior art date
Application number
SU1761120A
Other languages
Russian (ru)
Original Assignee
Иностранцы Франйо Кайфеж, Никола Блажевич , Витомир Шунйич
Иностранна фирма ЦРЦ Компань Ричерка Кимика
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иностранцы Франйо Кайфеж, Никола Блажевич , Витомир Шунйич, Иностранна фирма ЦРЦ Компань Ричерка Кимика filed Critical Иностранцы Франйо Кайфеж, Никола Блажевич , Витомир Шунйич
Application granted granted Critical
Publication of SU453842A3 publication Critical patent/SU453842A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

(54) СПОСОБ ПОЛУЧЕНИЯ ОПТИЧЕСКИ АКТИВНЫХ 1,4-БЕНЗОДИАЗЕПИНОВ N-C ..s-R, /V HN H где Ri-RS и A имеют указанные значени . Путем отщеплени  защитной групны А от соединений IV получаетс  свободна  аминогруппа , реагирующа  затем с карбонилгруппой , причем образуютс  соединени  общей формулы I. Согласно изобретению реакцию соединений II н III нровод т в инертном растворителе и отщепление защитной группы А от соединений общей формулы IV путем гидролиза в щелочной или кислой среде. Пример 1. 2,32 г (10 моль) 2-амино-5хлорбензофеноиа и 1,89 г (10 моль) BOC-Lаланииа раствор ют в 50 мл CHgClg и к полученному лед ному раствору прибавл ют при перемещивании 2,26 г (11 ммоль) DCCD (днциклокарбодиимид ). Через 30 мин удал ют холодильник и раствор перемешивают в течение суток при комнатной температуре. Раствор сохран ет желтый цвет отчасти непрореагировавшего амина. Выделившуюс  дициклогексилмочевину отсасывают и фильтрат упаривают до объема приблизительно 3-4 мл. Концентрированный раствор подвергают хроматографии на колонке (220 г силикагел , хлороформ - этилацетат 95:5) и из фракций 16-28 (по 50 мл) получают 69% сырого продукта формулы V Х. вают в течение получаса до 35-40С. Высушенные экстракты (CaCl2, Na2S04) упаривают и получают 90% сырого ( + )-7-хлор-1,3-дигидро-3-метил-5-фепил-2Н - 1,4-бензодиазепин-2оиа (3 S), очищенного перекристаллизацией из простого эфира. Точки плавлени : 163-165°С ЯМР(вСНС1з), И5,8 171,5, 201, .„в + 332,5, , . + 444, + 338° (С 1,56 в СНС1з). Пример 2. Н О ,ХНгс ) 0/v HN Н Соедииение VI приведенной формулы получают так же, как соедииение V, причем примен ют 2,65 г (10 ммоль) BOC-L-фенилаланина . Выдел ют сырой продукт после удалени  дициклогексилмочевины путем упаривани  растворител  в вакууме и последовательной кристаллизации остатка, начина  с 50 мл эфирного раствора. Получают 2,8 г (58,5%) сырого соединени  VI, т. пл. 135-139°С. После перекристаллизации из диоксана - петролейиого эфира (два раза) точка плавлени  повышаетс  до 14ГС. 1,5 г соединени  VI циклизируют согласно описанному в примере 1 способу. При этом получают 0,6 г сырого ( + )-7-хлор-1,3-дигидро3 - беизил-5-фенил - 1,4 - бензодиазеиин - 2-она (3S). П р и м е р 3. Аналогично примерам 1 и 2 получают при применении 1,5 г ВОС-тирозина соединени  VII и VIII, формулы которых приведены ниже.(54) METHOD FOR OBTAINING OPTICALLY ACTIVE 1,4-BENZODIAZEPINES N-C. S-R, / V HN H where Ri-RS and A have the indicated values. By cleaving the protective group A from compounds IV, a free amino group is obtained, which then reacts with the carbonyl group, and compounds of general formula I are formed. According to the invention, the reaction of compounds II and III is carried out in an inert solvent and the removal of protective group A from compounds of general formula IV or acidic environment. Example 1. 2.32 g (10 mol) of 2-amino-5-chlorobenzophenoia and 1.89 g (10 mol) of BOC-L alkania are dissolved in 50 ml of CHgClg and 2.26 g (11 mmol) DCCD (dicyclocarbodiimide). After 30 minutes, the refrigerator was removed and the solution was stirred at room temperature overnight. The solution retains the yellow color of a partly unreacted amine. The released dicyclohexyl urea is sucked off and the filtrate is evaporated to a volume of approximately 3-4 ml. The concentrated solution is subjected to chromatography on a column (220 g of silica gel, chloroform - ethyl acetate 95: 5) and 69% of the crude product of the formula V X is obtained from fractions 16-28 (50 ml each) in half an hour to 35-40 ° C. Dried extracts (CaCl2, Na2S04) are evaporated and 90% of crude (+) -7-chloro-1,3-dihydro-3-methyl-5-phenyl-2H - 1,4-benzodiazepin-2oia (3 S) purified by recrystallization from ether. Melting points: 163-165 ° C NMR (vSSN1z), I5.8 171.5, 201. In + 332.5,. + 444, + 338 ° (С 1.56 in СНС1з). EXAMPLE 2 H O, HNGs) 0 / v HN H Compound VI of the above formula is prepared in the same way as Compound V, and 2.65 g (10 mmol) of BOC-L-phenylalanine is used. The crude product is isolated after removing the dicyclohexyl urea by evaporation of the solvent in vacuo and successive crystallization of the residue, starting with 50 ml of ethereal solution. 2.8 g (58.5%) of crude compound VI are obtained, m.p. 135-139 ° C. After recrystallization from dioxane-petroleum ether (twice), the melting point rises to 14 ° C. 1.5 g of compound VI is cyclized as described in Example 1. At the same time, 0.6 g of crude (+) -7-chloro-1,3-dihydro3-beisyl-5-phenyl-1,4-benzodiaziein-2-one (3S) is obtained. EXAMPLE 3 Analogously to Examples 1 and 2, when using 1.5 g of BOC-tyrosine, Compounds VII and VIII are obtained, the formulas of which are given below.

с т. пл. 148-153°С. После многократной перекристаллизации из циклогексана продукт плавитс  при 153-155°С. ИК-иолосы (в КВг) отчетливо выражены при 3310, 1710 (плечо), 1678, 1648, 1575, 1520, 1490, 1285, 1250, 1160, 955 см-1.with t. pl. 148-153 ° C. After repeated recrystallization from cyclohexane, the product melts at 153-155 ° C. IR-hairs (in KBG) are clearly expressed at 3310, 1710 (shoulder), 1678, 1648, 1575, 1520, 1490, 1285, 1250, 1160, 955 cm-1.

Вычислено, %; С 62,61; Н 5,75; N 6,95.Calculated,%; C, 62.61; H 5.75; N 6.95.

C2lH23N2O4Cl.C2lH23N2O4Cl.

Найдено, %: С 62,48; Н 5,11; N 6,72.Found,%: C 62.48; H 5.11; N 6.72.

885 мг соединени  V раствор ют при перемещиваиии в 4 мл лед ной уксусной кислоты. К раствору добавл ют при интенсивном перемешивании 5 мл концеитрировапной НС1 и продолжают перемешивать в течение 10 мин, чтобы удалить пузырьки из раствора. Реакционную смесь прибавл ют по капл м к 100мл 10%-ного водного раствора Ма2СОз и нагре I II885 mg of Compound V is dissolved by transferring to 4 ml of glacial acetic acid. Under vigorous stirring, 5 ml of conicity with HCl is added to the solution and stirred for 10 minutes to remove the bubbles from the solution. The reaction mixture is added dropwise to 100 ml of a 10% aqueous solution of Ma2CO3 and heat I II

. ...СИ, . ... SI,

С1C1

Предмет изобретени Subject invention

1. Способ получени  оптически активных 1,4-бензодиазепинов общей формулы1. A method for producing optically active 1,4-benzodiazepines of the general formula

66

где RI и Rz имеют указанные значени , подвергают взаимодействию с соединением общей формулыwhere RI and Rz have the indicated meanings, are reacted with a compound of the general formula

,,

содержащих в положении 3 асимметрический атом углерода,containing in position 3 asymmetric carbon atom,

где RI - водород, галоген или нитрогрунпа, R2 - водород или низший алкил, содержащий до четырех атомов углерода ,where RI is hydrogen, halogen or nitrocorn, R2 is hydrogen or lower alkyl containing up to four carbon atoms,

Кз - нормальный или изо-низший алкил ,Cs - normal or iso-lower alkyl,

содержащий до трех атомов углерода, замещенный низщий алкил, бензил, п-оксибензил или триптофанилостаток, отличающийс  тем, что соединение общей формулыcontaining up to three carbon atoms, substituted lower alkyl, benzyl, p-hydroxybenzyl or tryptophanil residue, characterized in that the compound of the general formula

....

НООСх хВьNoos xB

СWITH

HN йHn th

Claims (2)

I АI a где Rs имеет указанные значени , А означает Н-НС1-группу, трег-бутоксикарбонилгруппу или фталимидную группу,where Rs has the indicated meanings, A is an H-HC1 group, a tre-butoxycarbonyl group or a phthalimide group, с последующей циклизацией промежуточно образующегос  соединени  общей формулыfollowed by cyclization of the intermediate compound of the general formula R ОR o I II . I ii. х x н. Xn X нn где RI-Rs и А имеют указанные значени , и выделением целевого продукта обычными приемами.where RI-Rs and A have the indicated meanings, and isolating the target product by conventional techniques. 2. Способ по п. 1, отличающийс  тем, что реакцию ведут в инертном растворителе.2. A method according to claim 1, characterized in that the reaction is carried out in an inert solvent.
SU1761120A 1971-03-17 1972-03-17 SU453842A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH386871A CH554349A (en) 1971-03-17 1971-03-17 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 1,3-DIHYDRO-2H-1,4-BENZODIAZEPINE-2-ONES.

Publications (1)

Publication Number Publication Date
SU453842A3 true SU453842A3 (en) 1974-12-15

Family

ID=4265209

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1761120A SU453842A3 (en) 1971-03-17 1972-03-17

Country Status (16)

Country Link
AT (1) AT327909B (en)
BE (1) BE780892A (en)
CA (1) CA992079A (en)
CH (1) CH554349A (en)
DE (1) DE2212526A1 (en)
ES (1) ES400851A1 (en)
FR (1) FR2130342B1 (en)
GB (2) GB1391081A (en)
HU (1) HU165496B (en)
IL (2) IL38991A (en)
NL (1) NL7203536A (en)
NO (1) NO137896C (en)
SE (1) SE399887B (en)
SU (1) SU453842A3 (en)
YU (1) YU34882B (en)
ZA (1) ZA721845B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602672A5 (en) * 1974-06-28 1978-07-31 Hoffmann La Roche
CH603655A5 (en) * 1974-10-21 1978-08-31 Hoffmann La Roche
EP1210338A2 (en) * 1999-08-05 2002-06-05 IGT Pharma Inc. 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system

Also Published As

Publication number Publication date
ZA721845B (en) 1972-12-27
YU34882B (en) 1980-04-30
IL38991A (en) 1976-09-30
HU165496B (en) 1974-09-28
FR2130342B1 (en) 1977-01-14
GB1391082A (en) 1975-04-16
IL47123A (en) 1976-09-30
NO137896B (en) 1978-02-06
ES400851A1 (en) 1975-01-16
FR2130342A1 (en) 1972-11-03
ATA214972A (en) 1975-05-15
BE780892A (en) 1972-07-17
IL38991A0 (en) 1972-05-30
CA992079A (en) 1976-06-29
CH554349A (en) 1974-09-30
DE2212526A1 (en) 1972-09-21
AT327909B (en) 1976-02-25
SE399887B (en) 1978-03-06
NL7203536A (en) 1972-09-19
NO137896C (en) 1978-05-16
YU69772A (en) 1979-10-31
GB1391081A (en) 1975-04-16

Similar Documents

Publication Publication Date Title
SU691089A3 (en) Method of producing carbonyl-substituted 1-sulphonylbenzimidazoles
HU195182B (en) Process for production of /z/-1-phenil-1-diethil-amino-carbonil-2-amino-methil-cyclopropan hcl
SU508199A3 (en) Method for producing morpholine derivatives
JP3973941B2 (en) Method for producing δ-aminopentadienoic acid ester derivative
SU453842A3 (en)
HU205116B (en) Process for producing 1,4-diazabicyclo/3.2.2./nonane
EP0092194B1 (en) Method of obtaining optically active half esters
NO883080L (en) PROCEDURE FOR THE MANUFACTURE OF NEW CEFEM COMPOUNDS.
US4049659A (en) Process for the preparation of 4-oxo-hexahydro-pyrazinoisoquinoline derivatives
EP0078804A1 (en) Method of preparation of delta2 n-heterocycles
EP0040332B1 (en) Antihypertensive lactams
EP0839800B1 (en) Process for preparing halogenoacetamide derivatives
US4443621A (en) p-Nitrophenyl 3-bromo-2,2-diethoxy-propionate and synthetic utility therefor
US4918190A (en) Crystalline complex compounds of propargyl alcohols and tertiary diamines, and process of separation and purification of propargyl alcohols using the same
US4564677A (en) Preparation of N-amino compounds
CA1202625A (en) Process for the preparation of 5, 11-dihydro-11-[(4- methyl-1-piperazinyl)acetyl]-6h-pyrido[2,3-b] [1,4] benzodiazepin-6-ones
US5290947A (en) Process for the preparation of pyrrole derivates
US4075219A (en) Epimerization process
FI69838C (en) REFERENCE TO A FRAMSTAELLNING AV 1,2,3-THIADIAZOLE-5-YLURINAEMNEN
SU461510A3 (en) Method for preparing alkylsulfonic acid esters of 1,3,2-oxazaphosphacyclic compounds
US4355166A (en) Quinuclidinic ester and derivatives of phenoxycarboxylic acids
US5338868A (en) Process for preparing alpha-amino-phenylacetic acid-trifluoromethane sulfonic acid mixed anhydrides
AT397385B (en) METHOD FOR PRODUCING CHINOLINE CARBONIC ACID DERIVATIVES
US4432901A (en) Beta-lactam compounds containing a C-acetal group and process for their preparation
SU561513A3 (en) The method of obtaining piperazine derivatives or their salts